(Q44664669)

English

S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.

scientific article published on 28 May 2013

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit